Prelude Therapeutics
PRLD
PRLD
61 hedge funds and large institutions have $1.12B invested in Prelude Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 57 → 61 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
61
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$19.5M | |
| 2 | +$15.7M | |
| 3 | +$6.17M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$6.11M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$3.03M |
Top Sellers
| 1 | -$6.3M | |
| 2 | -$1.6M | |
| 3 | -$959K | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$625K |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$439K |